Neu Health Announces Key Appointments to its Board of Directors
London, UK, 24 October 2023 – Neuhealth Digital (‘Neu Health’), an innovative neurology healthtech spinout from the University of Oxford, is pleased to announce the appointment of Dr John Glaser as Non-Executive Chair of the Board of Directors and Sean Slovenski as Non-Executive Director, effective immediately.
Dr John Glaser, Non-Executive Chair of the Board of Directors:
We are delighted to welcome Dr John Glaser as the newly appointed Chairman of the Board at Neu Health.
With over 35 years of extensive experience in the healthcare technology industry, John has held prominent roles as the CEO of Siemens Health Services, Senior Vice President of Population Health at Cerner, and VP and Chief Information Officer at Partners Healthcare.
He also serves as an Executive-in-Residence at Harvard Medical School, was formerly on the faculty of the Wharton School at the University of Pennsylvania, and is a Board Member for various digital health companies.
John's contributions include founding the College of Healthcare Information Management Executives (CHIME) and serving as the past-president of the Healthcare Information and Management Systems Society (HIMSS). He has held leadership positions in the American Telemedicine Association (ATA) and the Global Agenda Council on Digital Health at the World Economic Forum. Furthermore, he was a Senior Advisor to the US Office of the National Coordinator for Health Information Technology.
John is also a board member for the Scottsdale Institute, the ATA, Carleton Willard Village, and the National Committee for Quality Assurance (NCQA). Recognized with multiple industry awards, including the John P. Glaser Innovation Award (at the School of Biomedical Informatics, University of Texas Health Sciences Center) and the William B. Stead Thought Leadership Award (American Medical Informatics Association), his visionary leadership and strategic acumen will be instrumental in guiding Neu Health through a dynamic phase of growth and innovation.
Sean Slovenski, Independent Non-Executive Director:
We are equally thrilled to welcome Sean Slovenski as our Independent Non-Executive Director. Sean is a renowned healthcare industry innovator, having held significant positions such as President of Walmart Health and Wellness and President of Health & Productivity Solutions at Humana.
His leadership includes roles as President of Population Health for Sharecare, CEO of Care Innovations (a joint venture of Intel and GE Healthcare), and co-founder and CEO of Hummingbird Coaching Services (subsequently acquired by Humana).
Sean has received notable industry recognitions, such as Healthcare Leader of the Year by the US Chamber of Commerce in 2015 and being named one of the Top 100 most influential people in healthcare in 2019 by Modern Health Magazine. His insights and expertise will be invaluable to our board as we continue to expand Neu Health's presence in the United States.
Neu Health is committed to utilizing digital technology to make advanced Parkinson's Disease and Dementia care accessible to all. These strategic appointments underscore our unwavering dedication to leading neurology care into an exciting future.
“The need for evidence-based and digital advances in neurology care is crucial to tackling the growing challenges of neurology resource constraints”
Dr. Glaser expressed his motivation for this role, stating, "The need for evidence-based and digital advances in neurology care is crucial to tackling the growing challenges of neurology resource constraints and the increasing populations affected by these conditions. Members of my family are afflicted with neurodegenerative diseases, and it is a privilege to work with the Neu Health team to develop novel digital health approaches to help my family members, and yours, manage their health and live their lives to the fullest."
“I’m honored to be part of Neu Health’s journey, especially as I personally navigate the challenges faced by my family members dealing with the very issues Neu Health is focused on.”
Sean Slovenski added, "Introducing best practices from the management of other medical conditions into neurology could be a game-changer. I'm honored to be part of Neu Health's journey, especially as I personally navigate the challenges faced by my family members dealing with the very issues Neu Health is focused on. I look forward to contributing to redefining neurology care in the digital age."
Caroline Cake, CEO of Neu Health, remarked, "We're thrilled to welcome John and Sean to Neu Health. Their expertise and commitment to healthcare innovation will play a pivotal role in realizing our mission to enhance the lives of individuals living with Parkinson's and Dementia."
Neu Health is grateful for the support of our partners and employees who have been instrumental in reaching this milestone. We look forward to an exciting future as we continue to innovate, grow, and provide value to patients, clinicians, and healthcare systems.
About Neu Health:
Neu Health is a health-tech company based in London, UK, dedicated to making the latest Parkinson's disease and dementia care accessible to all. Established in 2022, the company leverages research, data, and clinical validation conducted by neurologists, neuroscientists, and data scientists in the laboratories of Professor Michele Hu and Professor Masud Husain at the University of Oxford. Neu Health successfully secured $3.6 million in financing from Oxford Science Enterprises to support research and development, regulatory strategy, product innovation, and market expansion.
